G01N 2333/4725
Mucins
Official title: Mucins, e.g. human intestinal mucin
G01N2333/4725 (Mucins) appears on 114 US grants and 241 published applications in this corpus.
Search patents in G01N- Granted patents
- 114
- Published applications
- 241
- Assignees
- 139
- Inventors
- 403
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 4 |
| 2003 | 1 | 6 |
| 2004 | 1 | 7 |
| 2005 | 1 | 1 |
| 2006 | 5 | 4 |
| 2007 | 2 | 7 |
| 2008 | 2 | 5 |
| 2009 | 1 | 9 |
| 2010 | 6 | 9 |
| 2011 | 7 | 16 |
| 2012 | 4 | 13 |
| 2013 | 7 | 9 |
| 2014 | 7 | 15 |
| 2015 | 9 | 10 |
| 2016 | 10 | 19 |
| 2017 | 3 | 17 |
| 2018 | 5 | 6 |
| 2019 | 10 | 16 |
| 2020 | 9 | 15 |
| 2021 | 4 | 7 |
| 2022 | 4 | 8 |
| 2023 | 3 | 7 |
| 2024 | 5 | 8 |
| 2025 | 5 | 12 |
| 2026 | 3 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Humanized antibody and method for using the same26 May 2026US 12,637,504 B2Nihon Medi-Physics Co., Ltd.
- Humanized antibodies to mucin-16 and methods of use thereof5 May 2026US 12,617,866 B2Eureka Therapeutics, Inc.
- Diagnostic antibodies against mucin 17 and uses thereof17 Mar 2026US 12,577,322 B2Amgen Inc.
- Adult stem cell compositions and methods of identification and isolation30 Dec 2025US 12,509,659 B2TACS Bio Inc.
- Colon and pancreas cancer peptidomimetics28 Oct 2025US 12,454,560 B2Precision Biologics, Inc.
- Ovarian cancer risk prediction13 Aug 2026US 2026/0235608 A1Arocell AB
- Muc5ac in pancreatic ductal adenocarcinoma6 Aug 2026US 2026/0226552 A1Ohio State Innovation Foundation
- Method of detecting disease-associated markers in a liquid biopsy sample using extracellular vesicles6 Aug 2026US 2026/0227404 A1The General Hospital Corporation
- Synthetic glycopeptides and derivatives for the early-stage detection of cancer biomarkers in muc1-positive tumors6 Aug 2026US 2026/0227407 A1
- Methods for the detection and treatment of lung cancer16 Jul 2026US 2026/0202411 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Diagnostic panel of cancer antibodies and methods for use77US 8,216,789 B2University of Washington · 2012
- Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen46US 7,655,461 B2University of Pittsbugh — Of the Commonwealth System of Higher Education · 2010
- Antibodies to non-shed Muc1 and Muc16, and uses thereof45US 7,202,346 B2ImmunoGen, Inc. · 2007
- Expression of human serum albumin (HSA) in monocot seeds27US 7,304,208 B2Ventria Bioscience · 2007
- Expression of human milk proteins in transgenic plants26US 7,417,178 B2Ventria Bioscience · 2008